ResMed Inc (RMD)
Cash ratio
Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cash and cash equivalents | US$ in thousands | 238,361 | 237,910 | 210,247 | 209,100 | 227,891 | 227,894 | 253,199 | 207,163 | 273,710 | 201,769 | 194,476 | 276,149 | 295,278 | 230,635 | 255,865 | 421,414 | 463,156 | 352,861 | 204,095 | 172,154 |
Short-term investments | US$ in thousands | 12,026 | 21,537 | 7,617 | 11,821 | 12,423 | 12,115 | 4,980 | — | 9,167 | 17,842 | 19,566 | 33,138 | — | 24,011 | — | 2,020 | — | — | — | — |
Total current liabilities | US$ in thousands | 910,655 | 773,030 | 764,073 | 770,802 | 758,533 | 761,691 | 732,714 | 692,659 | 689,299 | 667,265 | 621,064 | 624,158 | 911,766 | 876,541 | 577,335 | 590,853 | 602,761 | 551,519 | 500,045 | 550,457 |
Cash ratio | 0.27 | 0.34 | 0.29 | 0.29 | 0.32 | 0.32 | 0.35 | 0.30 | 0.41 | 0.33 | 0.34 | 0.50 | 0.32 | 0.29 | 0.44 | 0.72 | 0.77 | 0.64 | 0.41 | 0.31 |
June 30, 2024 calculation
Cash ratio = (Cash and cash equivalents + Short-term investments) ÷ Total current liabilities
= ($238,361K
+ $12,026K)
÷ $910,655K
= 0.27
The cash ratio for ResMed Inc fluctuated over the periods indicated in the table. The cash ratio measures a company's ability to cover its current liabilities with its cash and cash equivalents. A higher cash ratio suggests a stronger ability to cover short-term obligations.
Based on the data:
- The cash ratio ranged from a low of 0.27 to a high of 0.77.
- The ratio peaked at 0.77 on September 30, 2020, indicating that ResMed had a significant amount of cash and cash equivalents relative to its current liabilities at that time.
- The lowest point was at 0.27 on June 30, 2024, suggesting a decreased ability to cover short-term obligations with available cash.
Overall, ResMed's cash ratio has shown variability, which may reflect changes in the company's cash position and short-term liabilities over time. Investors and analysts may want to further investigate the reasons behind these fluctuations to assess the company's liquidity position and financial health.
Peer comparison
Jun 30, 2024